$3995 | Single User
$7990 | Site License
$11985 | Global License

Acne Vulgaris - Epidemiology Forecast to 2026
[Report Updated: 01-03-2018]

Published by Global Data: 01 Mar 2018 | 206717 | In Stock
Related Topics: Acne

Introduction

Acne Vulgaris - Epidemiology Forecast to 2026

Summary

Acne vulgaris (acne) is a chronic inflammatory skin disease that presents as open or closed comedones and inflammatory lesions. Comedones include blackheads and whiteheads, while inflammatory lesions include papules, pustules, or cysts. Acne is a common skin disease that predominantly affects adolescents and young adults, but can also persist into adulthood. Mortality is not associated with acne, although major physical and psychological characteristics may develop, such as acne scarring, poor self-esteem, depression, and anxiety. The distribution of acne in the population is influenced by genetic background and dietary habits.

For age- and sex-specific total prevalent cases, GlobalData epidemiologists utilized country-specific data from peer-reviewed journal articles, and for age-and sex-specific diagnosed prevalent cases and diagnosed prevalent cases by severity, GlobalData epidemiologists utilized a combination of primary research and data obtained from peer-reviewed journal articles. GlobalData epidemiologists forecast that the total prevalent cases of acne vulgaris in the 7MM will decrease by an Annual Growth Rate (AGR) of negative 0.13% per year over the next 10 years, from 157,919,985 cases in 2016 to 155,935,706 cases in 2026. GlobalData epidemiologists forecast that the diagnosed prevalent cases of acne vulgaris in the 7MM will decrease by an AGR of negative 0.13% per year over the next 10 years, from 78,960,002 cases in 2016 to 77,967,862 cases in 2026. In the 7MM, the US had the highest number of diagnosed prevalent cases with 32,308,734 in 2016, while Spain had the lowest number of diagnosed prevalent cases with 5,766,457 in 2016.

Scope

- The Acne Vulgaris report provides an overview of the risk factors and global trends for acne vulgaris in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan).

- It includes a 10-year epidemiological forecast for total and diagnosed prevalent cases of acne vulgaris segmented by sex and age (7-9 years, 10-17 years, and 18-60 years). Diagnosed prevalent cases of acne vulgaris are further segmented by severity (mild, moderate, severe) in both children and adolescents (7-17 years) and adults (18-60 years).

- The acne vulgaris epidemiology report is written and developed by Masters- and PhD-level epidemiologists.

- The Epidemiology Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.

Reasons to buy

The Acne Vulgaris Epidemiology report will allow you to -

- Develop business strategies by understanding the trends shaping and driving the global acne vulgaris market.

- Quantify patient populations in the global acne vulgaris market to improve product design, pricing, and launch plans.

- Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for acne vulgaris therapeutics in each of the markets covered.

- Understand magnitude of acne vulgaris population by disease severity.

Table of Contents
for Acne Vulgaris - Epidemiology Forecast to 2026 [Report Updated: 01-03-2018]

  • 1 Table of Contents

    1 Table of Contents 2

    1.1 List of Tables 3

    1.2 List of Figures 3

    2 Acne Vulgaris: Executive Summary 4

    2.1 Related Reports 6

    2.2 Upcoming Reports 7

    3 Epidemiology 8

    3.1 Disease Background 8

    3.2 Risk Factors and Comorbidities 8

    3.3 Global and Historical Trends 9

    3.3.1 US 11

    3.3.2 5EU 11

    3.3.3 Japan 12

    3.4 Forecast Methodology 13

    3.4.1 Sources 13

    3.4.2 Forecast Assumptions and Methods 16

    3.5 Epidemiological Forecast for Acne Vulgaris (2016-2026) 21

    3.5.1 Total Prevalent Cases of Acne Vulgaris 21

    3.5.2 Diagnosed Prevalent Cases of Acne Vulgaris 22

    3.5.3 Age-Specific Diagnosed Prevalent Cases of Acne Vulgaris 23

    3.5.4 Sex-Specific Diagnosed Prevalent Cases of Acne Vulgaris 24

    3.5.5 Diagnosed Prevalent Cases of Acne Vulgaris by Severity 25

    3.6 Discussion 27

    3.6.1 Epidemiological Forecast Insight 27

    3.6.2 Limitations of Analysis 27

    3.6.3 Strengths of Analysis 28

    4 Appendix 29

    4.1 Bibliography 29

    4.2 Primary Research - KOLs Interviewed for this Report 31

    4.3 Primary Research - Prescriber Survey 33

    4.4 About the Authors 34

    4.4.1 Epidemiologist 34

    4.4.2 Reviewers 34

    4.4.3 Global Director of Therapy Analysis and Epidemiology 35

    4.4.4 Global Head and EVP of Healthcare Operations and Strategy 36

    4.5 About GlobalData 37

    4.6 Contact Us 37

    4.7 Disclaimer 37

List Of Tables
in Acne Vulgaris - Epidemiology Forecast to 2026 [Report Updated: 01-03-2018]

1.1 List of Tables

Table 1: Risk Factors and Comorbidities for Diagnosed Prevalent Cases of Acne Vulgaris 9

Table 2: 7MM, Total Prevalent Cases of Acne Vulgaris, Ages 7-60 Years, Both Sexes, N, Select Years 2016-2026 22

Table 3: 7MM, Diagnosed Prevalent Cases of Acne Vulgaris, Ages 7-60 Years, Both Sexes, N, Select Years 2016-2026 23

Table 4: High-Prescribing Physicians (non-KOLs) Surveyed, By Country 34

List Of Figures, Charts and Diagrams
in Acne Vulgaris - Epidemiology Forecast to 2026 [Report Updated: 01-03-2018]

1.2 List of Figures

Figure 1: 7MM, Total Prevalent Cases of Acne Vulgaris, Both Sexes, Ages 7-60 Years, 2016 and 2026 5

Figure 2: 7MM, Diagnosed Prevalent Cases of Acne Vulgaris, Both Sexes, Ages 7-60 Years, 2016 and 2026 6

Figure 3: Age-Standardized Total Prevalence of Acne Vulgaris, Ages 7-60 Years, 2016 10

Figure 4: Age-Standardized Diagnosed Prevalence of Acne Vulgaris, Ages 7-60 Years, 2016 11

Figure 5: Sources Used and Not Used to Forecast Total Prevalent Cases of Acne Vulgaris 14

Figure 6: Sources Used to Forecast Diagnosed Prevalent Cases of Acne Vulgaris 15

Figure 7: Sources Used and Not Used to Forecast Diagnosed Prevalent Cases of Acne Vulgaris by Severity 16

Figure 8: 7MM, Age-Specific Diagnosed Prevalent Cases of Acne Vulgaris, Both Sexes, 2016 24

Figure 9: 7MM, Sex-Specific Diagnosed Prevalent Cases of Acne Vulgaris, Ages 7-60 Years, 2016 25

Figure 10: 7MM, Diagnosed Prevalent Cases of Acne Vulgaris, Ages 7-17 Years, Both Sexes, N, 2016 26

Figure 11: 7MM, Diagnosed Prevalent Cases of Acne Vulgaris, Ages 18-60 Years, Both Sexes, 2016 26

Additional Details

Publisher

Global Data

Publisher Information

Reference

206717 | GDHCER179-18

Number of Pages

37

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Acne Vulgaris Global Clinical Trials Review, H2, 2018
Acne Vulgaris Global Clinical Trials Review, H2, 2018SummaryGlobalData's clinical trial report, “Acn...
25 Oct 2018 by Global Data USD $2,500 More Info
Acne And Related Disorders Global Clinical Trials Review, H2, 2018
Acne And Related Disorders Global Clinical Trials Review, H2, 2018SummaryGlobalData's clinical trial...
25 Oct 2018 by Global Data USD $2,500 More Info
Global Acne Partnering 2010 to 2016
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and acce...
01 Nov 2016 by Current Partnering USD $1,495 More Info
Global Acne Partnering 2010 to 2016
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and acce...
01 Oct 2016 by Current Partnering USD $1,495 More Info
Acne Vulgaris Global Clinical Trials Review, H2, 2016
Acne Vulgaris Global Clinical Trials Review, H2, 2016SummaryGlobalData's clinical trial report, “Acn...
27 Jul 2016 by Global Data USD $2,500 More Info
Acne Vulgaris Global Clinical Trials Review, H2, 2016
Acne Vulgaris Global Clinical Trials Review, H2, 2016SummaryGlobalData's clinical trial report, “Acn...
27 Jul 2016 by Global Data USD $2,500 More Info
Acne Vulgaris Global Clinical Trials Review, H1, 2016
Acne Vulgaris Global Clinical Trials Review, H1, 2016SummaryGlobalData's clinical trial report, “Acn...
15 Apr 2016 by Global Data USD $2,500 More Info
Acne Vulgaris Global Clinical Trials Review, H1, 2016
Acne Vulgaris Global Clinical Trials Review, H1, 2016SummaryGlobalData's clinical trial report, “Acn...
15 Apr 2016 by Global Data USD $2,500 More Info
Acne And Related Disorders Global Clinical Trials Review, H2, 2015
Acne And Related Disorders Global Clinical Trials Review, H2, 2015SummaryGlobalData's clinical trial...
30 Nov 2015 by Global Data USD $2,500 More Info
Global Acne Treatment Market: Trends and Opportunities (2014-2019)
Scope of the ReportThe report titled “Global Acne Treatment Market: Trends and Opportunities (2014-2...
01 Jan 2015 by Daedal Research USD $800 More Info

This report is published by Global Data

Download Free Report Summary PDF

Acne Vulgaris - Epidemiology Forecast to 2026 [Report Updated: 01-03-2018] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • 360i Research
  • 99Strategy
  • Allied Market Research
  • Asia Market Information & Development Co.
  • Azoth Analytics
  • BioInformant
  • Black Swan Analysis
  • Canadean
  • CBR Pharma Insights
  • CRI
  • Current Analysis
  • Current Partnering
  • Daedal Research
  • Data bridge
  • Delve Insight
  • DPI Research
  • FirstWord Pharma
  • Future Market Insights
  • GBI Research
  • Global Data
  • Global Markets Direct
  • Global Research and Data Services GRDS
  • GMR Data
  • HeyReport
  • HongChun
  • HTStec
  • ICD Research
  • iGATE Research
  • IMARC
  • Industry ARC
  • Inkwood Research
  • IQ4I
  • Jain PharmaBiotech
  • Kelly Scientific
  • La Merie
  • Lifescience Intellipedia
  • LP Information
  • Market Data Forecast
  • Market Research Future
  • Marketline
  • MarketsandMarkets
  • McDerson
  • MedMarket Diligence
  • Meticulous Research
  • MicroMarketMonitor
  • MIReports
  • Mordor Intelligence LLC
  • MP Advisors
  • Occams Business Research
  • Prof Research
  • Progressive Markets
  • ProGrow Pharma Partners
  • Renub
  • Research Impact
  • RNCOS
  • Rockville Research
  • S&P Consulting
  • StratisticsMRC
  • The Business Research Company
  • Triton Market Research
  • Venture Planning Group (VPG)